These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 3074984)

  • 21. The role of iron overload in Yersinia enterocolitica and Yersinia pseudotuberculosis bacteremia in hemodialysis patients.
    Boelaert JR; van Landuyt HW; Valcke YJ; Cantinieaux B; Lornoy WF; Vanherweghem JL; Moreillon P; Vandepitte JM
    J Infect Dis; 1987 Aug; 156(2):384-7. PubMed ID: 3598237
    [No Abstract]   [Full Text] [Related]  

  • 22. Iron therapy in hemodialysis patients: time for a reappraisal.
    Human LE
    JAMA; 1980 Jul; 244(4):371. PubMed ID: 7392133
    [No Abstract]   [Full Text] [Related]  

  • 23. Intestinal mucormycosis in hemodialysis patients following deferoxamine.
    Eiser AR; Slifkin RF; Neff MS
    Am J Kidney Dis; 1987 Jul; 10(1):71-3. PubMed ID: 3605086
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mucormycosis infection in dialysis patients.
    Boelaert JR; Vergauwe PL; Vandepitte JM
    Ann Intern Med; 1987 Nov; 107(5):782-3. PubMed ID: 3662297
    [No Abstract]   [Full Text] [Related]  

  • 25. Localization and fate of Absidia ramosa spores after intravenous inoculation of mice.
    Smith JM; Jones RH
    J Comp Pathol; 1973 Jan; 83(1):49-55. PubMed ID: 4731309
    [No Abstract]   [Full Text] [Related]  

  • 26. Epidemic of iron overload in dialysis population caused by intravenous iron products: a plea for moderation.
    Vaziri ND
    Am J Med; 2012 Oct; 125(10):951-2. PubMed ID: 22795817
    [No Abstract]   [Full Text] [Related]  

  • 27. Maximal standard dose of parenteral iron for hemodialysis patients: an MRI-based decision tree learning analysis.
    Rostoker G; Griuncelli M; Loridon C; Magna T; Janklewicz P; Drahi G; Dahan H; Cohen Y
    PLoS One; 2014; 9(12):e115096. PubMed ID: 25506921
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Three autopsy cases of generalized mucormycosis with lung involvement complicating lymphoma and leukemia].
    Sugiyama Y; Izumi T; Sasaki K; Kitamura S; Takaku F; Yamaguchi K
    Nihon Kyobu Shikkan Gakkai Zasshi; 1984 Mar; 22(3):214-9. PubMed ID: 6748402
    [No Abstract]   [Full Text] [Related]  

  • 29. Desferrioxamine in the management of dialysis hemosiderosis.
    Krumlovsky FA
    Int J Artif Organs; 1982 Jul; 5(4):223-5. PubMed ID: 7118282
    [No Abstract]   [Full Text] [Related]  

  • 30. HFE gene mutation is a risk factor for tissue iron accumulation in hemodialysis patients.
    Turkmen E; Yildirim T; Yilmaz R; Hazirolan T; Eldem G; Yilmaz E; Aybal Kutlugun A; Altindal M; Altun B
    Hemodial Int; 2017 Jul; 21(3):359-366. PubMed ID: 28111930
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Listeriosis in a patient with long-term hemodialysis but without iron overload.
    Bufano G; Ceruti T; Ferrari L; Pecchini F
    Nephron; 1995; 69(3):356. PubMed ID: 7753284
    [No Abstract]   [Full Text] [Related]  

  • 32. [Anemia and iron stores in patients during hemodialysis and after renal transplantation [].
    Piedras J; Córdova MS; Alvarez-Hernández X; Wadgymar A; Hernández G; Peña JC
    Rev Invest Clin; 1982; 34(2):129-32. PubMed ID: 6750733
    [No Abstract]   [Full Text] [Related]  

  • 33. [Iron requirements of hemodialysis patients. Serum ferritin as an indicator].
    Hunderi OH
    Tidsskr Nor Laegeforen; 1986 Apr; 106(9):738-40. PubMed ID: 3705034
    [No Abstract]   [Full Text] [Related]  

  • 34. Iron in the treatment of anemia in dialysis patients: an important support to erythropoietin.
    Gallieni M
    Int J Artif Organs; 1998 Nov; 21(11):681-6. PubMed ID: 9894741
    [No Abstract]   [Full Text] [Related]  

  • 35. Liver Iron Load Influences Hepatic Fat Fraction in End-Stage Renal Disease Patients on Dialysis: A Proof of Concept Study.
    Rostoker G; Loridon C; Griuncelli M; Rabaté C; Lepeytre F; Ureña-Torres P; Issad B; Ghali N; Cohen Y
    EBioMedicine; 2019 Jan; 39():461-471. PubMed ID: 30502056
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intravenous iron exposure and outcomes in patients on hemodialysis.
    Fishbane S; Mathew AT; Wanchoo R
    Clin J Am Soc Nephrol; 2014 Nov; 9(11):1837-9. PubMed ID: 25318752
    [No Abstract]   [Full Text] [Related]  

  • 37. Pleural mucormycosis (zygomycosis).
    Green WR; Bouchette D
    Arch Pathol Lab Med; 1986 May; 110(5):441-2. PubMed ID: 3754429
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Minimizing anemia in the chronic hemodialysis patient.
    Norris SH; Kurtzman NA
    Int J Artif Organs; 1986 Jul; 9(4):199-206. PubMed ID: 3781644
    [No Abstract]   [Full Text] [Related]  

  • 39. Evidence for tissue iron overload in long-term hemodialysis patients and the impact of withdrawing parenteral iron.
    Ghoti H; Rachmilewitz EA; Simon-Lopez R; Gaber R; Katzir Z; Konen E; Kushnir T; Girelli D; Campostrini N; Fibach E; Goitein O
    Eur J Haematol; 2012 Jul; 89(1):87-93. PubMed ID: 22435497
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Listeriosis in patients with long-term hemodialysis and transfusional iron overload.
    Mossey RT; Sondheimer J
    Am J Med; 1985 Sep; 79(3):397-400. PubMed ID: 4036991
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.